These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 30410595)
1. Identifying a Novel Biomarker Xiong Y; Yuan L; Chen L; Zhu Y; Zhang S; Liu X; Xiao Y; Wang X J Cancer; 2018; 9(21):3912-3922. PubMed ID: 30410595 [TBL] [Abstract][Full Text] [Related]
2. Co-expression network analysis identified six hub genes in association with progression and prognosis in human clear cell renal cell carcinoma (ccRCC). Yuan L; Chen L; Qian K; Qian G; Wu CL; Wang X; Xiao Y Genom Data; 2017 Dec; 14():132-140. PubMed ID: 29159069 [TBL] [Abstract][Full Text] [Related]
3. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis. Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578 [TBL] [Abstract][Full Text] [Related]
4. Identification of 9 key genes and small molecule drugs in clear cell renal cell carcinoma. Luo Y; Shen D; Chen L; Wang G; Liu X; Qian K; Xiao Y; Wang X; Ju L Aging (Albany NY); 2019 Aug; 11(16):6029-6052. PubMed ID: 31422942 [TBL] [Abstract][Full Text] [Related]
5. Identification of key genes and pathways in human clear cell renal cell carcinoma (ccRCC) by co-expression analysis. Yuan L; Zeng G; Chen L; Wang G; Wang X; Cao X; Lu M; Liu X; Qian G; Xiao Y; Wang X Int J Biol Sci; 2018; 14(3):266-279. PubMed ID: 29559845 [TBL] [Abstract][Full Text] [Related]
6. ACAT1 and Metabolism-Related Pathways Are Essential for the Progression of Clear Cell Renal Cell Carcinoma (ccRCC), as Determined by Co-expression Network Analysis. Chen L; Peng T; Luo Y; Zhou F; Wang G; Qian K; Xiao Y; Wang X Front Oncol; 2019; 9():957. PubMed ID: 31649873 [TBL] [Abstract][Full Text] [Related]
7. Three novel hub genes and their clinical significance in clear cell renal cell carcinoma. Xiao H; Chen P; Zeng G; Xu D; Wang X; Zhang X J Cancer; 2019; 10(27):6779-6791. PubMed ID: 31839812 [No Abstract] [Full Text] [Related]
8. Identification of Yang H; Wang Y; Zhang Z; Li H Front Genet; 2020; 11():905. PubMed ID: 32973873 [TBL] [Abstract][Full Text] [Related]
9. Identification of Biomarkers Associated With Pathological Stage and Prognosis of Clear Cell Renal Cell Carcinoma by Co-expression Network Analysis. Chen L; Yuan L; Qian K; Qian G; Zhu Y; Wu CL; Dan HC; Xiao Y; Wang X Front Physiol; 2018; 9():399. PubMed ID: 29720944 [TBL] [Abstract][Full Text] [Related]
10. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis. Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363 [TBL] [Abstract][Full Text] [Related]
11. Bioinformatic analysis identifies potentially key differentially expressed genes in oncogenesis and progression of clear cell renal cell carcinoma. Zhang H; Zou J; Yin Y; Zhang B; Hu Y; Wang J; Mu H PeerJ; 2019; 7():e8096. PubMed ID: 31788359 [TBL] [Abstract][Full Text] [Related]
12. Co-expression network analysis identified FCER1G in association with progression and prognosis in human clear cell renal cell carcinoma. Chen L; Yuan L; Wang Y; Wang G; Zhu Y; Cao R; Qian G; Xie C; Liu X; Xiao Y; Wang X Int J Biol Sci; 2017; 13(11):1361-1372. PubMed ID: 29209141 [TBL] [Abstract][Full Text] [Related]
13. Co-Expression Network Analysis Identified LTF in Association with Metastasis Risk and Prognosis in Clear Cell Renal Cell Carcinoma. Ni L; Yuan C; Zhang C; Xiang Y; Wu J; Wang X; Wu X Onco Targets Ther; 2020; 13():6975-6986. PubMed ID: 32764988 [TBL] [Abstract][Full Text] [Related]
14. The Identification of Key Gene Expression Signature and Biological Pathways in Metastatic Renal Cell Carcinoma. Bao L; Zhao Y; Liu C; Cao Q; Huang Y; Chen K; Song Z J Cancer; 2020; 11(7):1712-1726. PubMed ID: 32194783 [No Abstract] [Full Text] [Related]
15. Bioinformatic analysis identifying FGF1 gene as a new prognostic indicator in clear cell Renal Cell Carcinoma. Zhang X; Wang Z; Zeng Z; Shen N; Wang B; Zhang Y; Shen H; Lu W; Wei R; Ma W; Wang C Cancer Cell Int; 2021 Apr; 21(1):222. PubMed ID: 33865387 [TBL] [Abstract][Full Text] [Related]
16. Identification of a Novel Immune-Related Prognostic Biomarker and Small-Molecule Drugs in Clear Cell Renal Cell Carcinoma (ccRCC) by a Merged Microarray-Acquired Dataset and TCGA Database. Xiao GF; Yan X; Chen Z; Zhang RJ; Liu TZ; Hu WL Front Genet; 2020; 11():810. PubMed ID: 33014010 [TBL] [Abstract][Full Text] [Related]
17. GNRH1 and LTB4R might be novel immune-related prognostic biomarkers in clear cell renal cell carcinoma (ccRCC). Wu HH; Yan X; Chen Z; Du GW; Bai XJ; Tuoheti K; Liu TZ Cancer Cell Int; 2021 Jul; 21(1):354. PubMed ID: 34229684 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of Topoisomerase 2-Alpha Confers a Poor Prognosis in Pancreatic Adenocarcinoma Identified by Co-Expression Analysis. Zhou Z; Liu S; Zhang M; Zhou R; Liu J; Chang Y; Zhao Q Dig Dis Sci; 2017 Oct; 62(10):2790-2800. PubMed ID: 28815403 [TBL] [Abstract][Full Text] [Related]
19. LGALS1 was related to the prognosis of clear cell renal cell carcinoma identified by weighted correlation gene network analysis combined with differential gene expression analysis. Fang J; Wang X; Xie J; Zhang X; Xiao Y; Li J; Luo G Front Genet; 2022; 13():1046164. PubMed ID: 36712844 [TBL] [Abstract][Full Text] [Related]
20. Functional Assessment of Four Novel Immune-Related Biomarkers in the Pathogenesis of Clear Cell Renal Cell Carcinoma. Lv D; Wu X; Wang M; Chen W; Yang S; Liu Y; Zeng G; Gu D Front Cell Dev Biol; 2021; 9():621618. PubMed ID: 33796525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]